Effects Of Prednisolone On Rheumatoid Arthritis Patients

Completed

Conditions studied: Arthritis, Rheumatoid

In brief

This study will assess the Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of Prednisolone on Rheumatoid Arthritis (RA) patients.

Key facts

Study ID

NCT00330889

Run by

GlaxoSmithKline

People needed

32

Starts

2004-02-01

Expected to finish

2006-12-01

Last updated by the study team

2012-10-22

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet the ACR criteria for diagnosis of rheumatoid arthritis.
• Required treatment with Prednisolone.
• Currently on a non-steroidal anti-inflammatory agent (NSAID).
• Willing to stay on current dose of NSAID for two weeks during study.

You may not qualify if…

• Major health issues such as osteoporosis, diabetes, heart failure, heart attack, kidney failure, or acute infection.

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Winnipeg, Manitoba, Canada
• GSK Investigational Site — Sheffield, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.